Thank you, Mr. Chair.
I want to pick up on that point because, Mr. Fleury, we all heard testimony from you and the stakeholders about how much the IRB advanced. You were rightly very proud of the work you did and the progress you made as a chair and, previous to that, as executive director.
So I really find it surprising that you said a minute ago that you found your presence as chair—and these are my words—an impediment, or as you said, a liability. Could you please elaborate on that? How could you—especially after talking about your success regarding professionalization, governance, and independence—still feel that you were an impediment or a liability?